nach oben

Erschienen in:

01.12.2015 | Research Article

BMP-2 induces motility and invasiveness by promoting colon cancer stemness through STAT3 activation

verfasst von: Bo Ram Kim, Sang Cheul Oh, Dae-Hee Lee, Jung Lim Kim, Suk Young Lee, Myoung Hee Kang, Sun Il Lee, Sanghee Kang, Sung Yup Joung, Byung Wook Min

Erschienen in: Tumor Biology | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

Bone morphogenetic proteins (BMPs) have been involved in metastatic progression and tumorigenesis of many cancer types. However, it remains unclear how BMP-2 contributes to the initiation and development of these cancers. Here, we investigated the role of BMP-2 in colon cancer stem cell (CSC) development from colon cancer cells. We also determined the effects of BMP-2 on CSC development and epithelial-mesenchymal transition (EMT) in human colon cancer cell lines HCT-116 and SW620. We found that BMP-2 enhanced sphere formation of colon cancer cells without serum. Also, BMP-2-induced spheres displayed up-regulation of stemness markers (CD133+ and EpCAM+) and increased drug resistance, hallmarks of CSCs. Importantly, expression of EMT activators p-Smad1/5 and Snail and N-cadherin was increased in the spheres’ cells, indicating that BMP-2 signaling might result in CSC self-renewal and EMT. Furthermore, siRNA-mediated knockdown of signal transducer and activator of transcription 3 (STAT3) in HCT-116 cells reversed BMP-2-induced EMT and stem cell formation. Taken together, our results suggest that the BMP-2 induced STAT3-mediated induction of colon cancer cell metastasis requires an EMT and/or changes in CSC markers.

Wolpin BM, Mayer RJ. Systemic treatment of colorectal cancer. Gastroenterology. 2008;134:1296–310.CrossRefPubMedPubMedCentral

Lai YL, Lin JK, Liang WY, Huang YC, Chang SC. Surgical resection combined with chemotherapy can help achieve better outcomes in patients with primary colonic lymphoma. J Surg Oncol. 2011;104:265–8.CrossRefPubMed

Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol. 2007;23:675–99.CrossRefPubMed

Smalley MJ, Dale TC. Wnt signalling in mammalian development and cancer. Cancer Metastasis Rev. 1999;18:215–30.CrossRefPubMed

Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, et al. Hedgehog signaling and bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 2006;66:6063–71.CrossRefPubMedPubMedCentral

Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS. Role of notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res: BCR. 2004;6:R605–15.CrossRefPubMedPubMedCentral

Yeung TM, Gandhi SC, Wilding JL, Muschel R, Bodmer WF. Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci U S A. 2010;107:3722–7.CrossRefPubMedPubMedCentral

Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A. 2007;104:10158–63.CrossRefPubMedPubMedCentral

Hardwick JCH, Van Den Brink GR, Bleuming SA, Ballester I, Van Den Brande JMH, Keller JJ, et al. Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. Gastroenterology. 2004;126:111–21.CrossRefPubMed

10.

Miyazono K, Kusanagi K, Inoue H. Divergence and convergence of tgf-beta/bmp signaling. J Cell Physiol. 2001;187:265–76.CrossRefPubMed

11.

Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K. Two major smad pathways in tgf-beta superfamily signalling. Genes Cells: Devoted Mol Cell Mech. 2002;7:1191–204.CrossRef

12.

Shirai YT, Ehata S, Yashiro M, Yanagihara K, Hirakawa K, Miyazono K. Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma. Am J Pathol. 2011;179:2920–30.CrossRefPubMedPubMedCentral

13.

Zhang Y, Chen X, Qiao M, Zhang BQ, Wang N, Zhang Z, et al. Bone morphogenetic protein 2 inhibits the proliferation and growth of human colorectal cancer cells. Oncol Rep. 2014;32:1013–20.PubMedPubMedCentral

14.

Kang MH, Oh SC, Lee HJ, Kang HN, Kim JL, Kim JS, et al. Metastatic function of bmp-2 in gastric cancer cells: the role of pi3k/akt, mapk, the nf-kappab pathway, and mmp-9 expression. Exp Cell Res. 2011;317:1746–62.CrossRefPubMed

15.

Fong YC, Li TM, Wu CM, Hsu SF, Kao ST, Chen RJ, et al. Bmp-2 increases migration of human chondrosarcoma cells via pi3k/akt pathway. J Cell Physiol. 2008;217:846–55.CrossRefPubMed

16.

Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, Langenfeld J. The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of a549 cells. Carcinogenesis. 2003;24:1445–54.CrossRefPubMed

17.

Thiery JP. Epithelial–mesenchymal transitions in development and pathologies. Curr Opin Cell Biol. 2003;15:740–6.CrossRefPubMed

18.

Bedi S, Vidyasagar A, Djamali A. Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev. 2008;22:1–5.CrossRef

19.

Moustakas A, Heldin CH. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 2007;98:1512–20.CrossRefPubMed

20.

Tsai JH, Yang J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013;27:2192–206.CrossRefPubMedPubMedCentral

21.

Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–90.CrossRefPubMed

22.

Gupta PB, Chaffer CL, Weinberg RA. Cancer stem cells: mirage or reality? Nat Med. 2009;15:1010–2.CrossRefPubMed

23.

Kang MH, Kim JS, Seo JE, Oh SC, Yoo YA. Bmp2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (pi3k)/akt pathway. Exp Cell Res. 2010;316:24–37.CrossRefPubMed

24.

Kryczek I, Lin Y, Nagarsheth N, Peng D, Zhao L, Zhao E, et al. Il-22(+)cd4(+) t cells promote colorectal cancer stemness via stat3 transcription factor activation and induction of the methyltransferase dot1l. Immunity. 2014;40:772–84.CrossRefPubMedPubMedCentral

25.

Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, Renauld JC. Interleukin-22 (il-22) activates the jak/stat, erk, jnk, and p38 map kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from il-10. J Biol Chem. 2002;277:33676–82.CrossRefPubMed

26.

Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, et al. Stat3 links il-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med. 2009;206:1465–72.CrossRefPubMedPubMedCentral

27.

Hogan BL. Bone morphogenetic proteins in development. Curr Opin Genet Dev. 1996;6:432–8.CrossRefPubMed

28.

Urist MR. Bone: formation by autoinduction. Science (New York, NY). 1965;150:893–9.CrossRef

29.

Reddi AH. Bone and cartilage differentiation. Curr Opin Genet Dev. 1994;4:737–44.CrossRefPubMed

30.

Liao A, Wang W, Sun D, Jiang Y, Tian S, Li J, Yang X, Shi R. Bone morphogenetic protein 2 mediates epithelial-mesenchymal transition via akt and erk signaling pathways in gastric cancer. Tumour Biol. 2015;36:2773–78.

31.

Hou CH, Hsiao YC, Fong YC, Tang CH. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13. Bone. 2009;44:233–42.CrossRefPubMed

32.

Kang MH, Kang HN, Kim JL, Kim JS, Oh SC, Yoo YA. Inhibition of pi3 kinase/akt pathway is required for bmp2-induced emt and invasion. Oncol Rep. 2009;22:525–34.PubMed

33.

Piccirillo SG, Vescovi AL. Bone morphogenetic proteins regulate tumorigenicity in human glioblastoma stem cells. Ernst Schering Found Symp Proc. 2006;5:59–81.

34.

Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, et al. Cd133 expression is not restricted to stem cells, and both cd133+ and cd133- metastatic colon cancer cells initiate tumors. J Clin Investig. 2008;118:2111–20.PubMedPubMedCentral

35.

Langan RC, Mullinax JE, Raiji MT, Upham T, Summers T, Stojadinovic A, et al. Colorectal cancer biomarkers and the potential role of cancer stem cells. J Cancer. 2013;4:241–50.CrossRefPubMedPubMedCentral

36.

Chambers I, Tomlinson SR. The transcriptional foundation of pluripotency. Development. 2009;136:2311–22.CrossRefPubMedPubMedCentral

37.

Liao T, Kaufmann AM, Qian X, Sangvatanakul V, Chen C, Kube T, et al. Susceptibility to cytotoxic t cell lysis of cancer stem cells derived from cervical and head and neck tumor cell lines. J Cancer Res Clin Oncol. 2013;139:159–70.CrossRefPubMed

38.

Lu Y, Zhu H, Shan H, Lu J, Chang X, Li X, et al. Knockdown of oct4 and nanog expression inhibits the stemness of pancreatic cancer cells. Cancer Lett. 2013;340:113–23.CrossRefPubMed

39.

Ma L, Lu MF, Schwartz RJ, Martin JF. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development. 2005;132:5601–11.CrossRefPubMed

40.

Ghosh-Choudhury N, Mandal CC, Choudhury GG. Statin-induced ras activation integrates the phosphatidylinositol 3-kinase signal to akt and mapk for bone morphogenetic protein-2 expression in osteoblast differentiation. J Biol Chem. 2007;282:4983–93.CrossRefPubMed

41.

Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, Choudhury GG. Requirement of bmp-2-induced phosphatidylinositol 3-kinase and akt serine/threonine kinase in osteoblast differentiation and smad-dependent bmp-2 gene transcription. J Biol Chem. 2002;277:33361–8.CrossRefPubMed

42.

Kashyap V, Rezende NC, Scotland KB, Shaffer SM, Persson JL, Gudas LJ, et al. Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the nanog, oct4, and sox2 pluripotency transcription factors with polycomb repressive complexes and stem cell micrornas. Stem Cells Dev. 2009;18:1093–108.CrossRefPubMedPubMedCentral

43.

Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell. 2009;4:472–6.CrossRefPubMedPubMedCentral

Titel: BMP-2 induces motility and invasiveness by promoting colon cancer stemness through STAT3 activation
verfasst von: Bo Ram Kim
Sang Cheul Oh
Dae-Hee Lee
Jung Lim Kim
Suk Young Lee
Myoung Hee Kang
Sun Il Lee
Sanghee Kang
Sung Yup Joung
Byung Wook Min
Publikationsdatum: 01.12.2015
Verlag: Springer Netherlands
Erschienen in: Tumor Biology / Ausgabe 12/2015
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-015-3681-y

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

BMP-2 induces motility and invasiveness by promoting colon cancer stemness through STAT3 activation

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2015

ABCG2 is a potential marker of tumor-initiating cells in breast cancer

Astrocyte-elevated gene-1 mediates insulin-like growth factor 1-induced the progression of cardiac myxoma

Association between cell cycle gene transcription and tumor size in oral squamous cell carcinoma

Elevated expression of TGIF is involved in lung carcinogenesis

TLR2∆22 (-196-174) significantly increases the risk of breast cancer in females carrying proline allele at codon 72 of TP53 gene: a case–control study from four ethnic groups of North Eastern region of India

Interaction between TNFR1 and TNFR2 dominates the clinicopathologic features of human hypopharyneal carcinoma

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie